Screening compound: C31H40N2O6 (K087-0023)

Screening compound: C<sub>31</sub>H<sub>40</sub>N<sub>2</sub>O<sub>6</sub> (K087-0023)
Screening compound: C<sub>31</sub>H<sub>40</sub>N<sub>2</sub>O<sub>6</sub> (K087-0023) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C31H40N2O6 (K087-0023)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K087-0023

Molecular Formula

C31H40N2O6 (C31 H40 N2 O6)

Compound Name

N'-[(E)-[3a,5a,7-trihydroxy-11a-methyl-1-(5-oxo-2,5-dihydrofuran-3-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-9a-yl]methylidene]-2-phenylacetohydrazide

IUPAC name

N'-[(E)-[(3bR7R9bS)-3a5a7-trihydroxy-11a-methyl-1-(5-oxo-25-dihydrofuran-3-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-9a-yl]methylidene]-2-phenylacetohydrazide

SMILES

CC(CC[C@@H]([C@H]1CCC2(C[C@@H](CC3)O)O)C23/C=N/NC(Cc2ccccc2)=O)(C(CC2)C(CO3)=CC3=O)C12O

InChI

InChI=1S/C31H40N2O6/c1-28-11-8-24-25(31(28,38)14-10-23(28)21-16-27(36)39-18-21)9-13-30(37)17-22(34)7-12-29(24,30)19-32-33-26(35)15-20-5-3-2-4-6-20/h2-6,16,19,22-25,34,37-38H,7-15,17-18H2,1H3,(H,33,35)/t22-,23?,24+,25+,28?,29?,30?,31?/m0/s1

InChI Key

JESBVNUXTAATBJ-KLJAJDIFSA-N

MDL Number (MFCD)

MFCD01538953

C31H40N2O6 (K087-0023) in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

CORONAVIRUS Library (20774 compounds)

Dark Chemical Matter Library (18430 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Steroid-like Compounds (494 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cardiovascular
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • 3D
  • Pool
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C31H40N2O6 (K087-0023) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C31H40N2O6 (K087-0023)?
Check Price and Availability of C31H40N2O6 (K087-0023), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C31H40N2O6 (K087-0023) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C31H40N2O6 (K087-0023)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C31H40N2O6 (K087-0023)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C31H40N2O6 (K087-0023) available by request